The European Union authorized the vaccine from the Anglo-Swedish laboratory on Friday. A few hours earlier, Emmanuel Macron had expressed his doubts about its effectiveness on the elderly.
In the wake of the European green light given on Friday, French health authorities will vote on the Covid-19 vaccine developed by AstraZeneca on Tuesday.
“The High Authority for Health (HAS) will deliver its opinion on Tuesday,” said Minister of Solidarity and Health Olivier Véran in an interview with Sunday newspaper published today.
“By giving its authorization on Friday, the European Medicines Agency specified that it could be used on all adults, despite incomplete data on the over 65s. She added that additional efficacy studies in the oldest people were expected in February, ”he added.
“In the light of this information, I developed a strategy for this vaccine which I will propose to the President, once the opinion of the HAS is known”, developed Olivier Véran, specifying that “we will have in February a reduced number of doses of this vaccine due to delays in delivery attributable to the laboratory “.
Macron expresses doubts about this vaccine
Friday, a few hours before the European verdict, Emmanuel Macron had expressed doubts about the effectiveness of the drug in the elderly.
“The first feedback we have today is not encouraging for those over 60-65 years old,” said the Head of State.
A position in tune with that of the German health authorities. On Thursday, the country’s vaccination commission said it recommended this vaccine only to people under the age of 65, due to the lack of data for people beyond that age. Same story, Saturday, on the side of the Italian health authorities.
—
